Found 336 hits.
| 242 | Zhao, Z. *, Ji, C. *, Yu, W. *, Meng, L., Hawro, T., Wei, J. F.+, and Maurer, M.: Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials. J. Allergy Clin. Immunol. 2016: 137; 1742-1750. IF: 13.08 |
| 372 | Kolkhir, P., Church, M. K., Altrichter, S., Stahl Skov, P., Hawro, T., Frischbutter, S., Metz, M., and Maurer, M.+: Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment. J. Allergy Clin. Immunol. Pract. 2020: 8; 318-325. IF: 8.86 |
o.372
| 165. | Gonçalo, M.+, Giménez-Arnau, A., Al-Ahmad, M., Ben-Shoshan, M., Bernstein, J., Ensina, L. F., Fomina, D., Galvàn, C. A., Godse, K., Grattan, C., Hide, M., Katelaris, C. H., Khoshkhui, M., Kocatürk, E., Kulthanan, K., Medina, I., Nasr, I., Peter, J., Staubach, P., Wang, L., Weller, K., and Maurer, M.: The global burden of chronic urticaria for the patient and society. Brit. J. Dermatol. 2021: 184; 226-236. IF: 11.11 |
r.165
| 172 | Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., Baiardini, I., Panagiotakos, D., Braido, F., and Maurer, M.+: Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 2013: 226; 371-379. IF: 1.68 |
| 175 | Nelissen, S., Vangansewinkel, T., Geurts, N., Geboes, L., Lemmens, E., Vidal, P. M., Lemmens, S., Willems, L., Boato, F., Dooley, D., Pehl, D., Pejler, G., Maurer, M. Metz, M., and Hendrix, S.+: Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4. Neurobiol. Dis. 2013: 62C; 260-272. IF: 5.20 |
o.175
| 71 | Altrichter, S., Boodstein, N., and Maurer, M.+: Matrix metalloproteinase-9: A novel biomarker for monitoring disease activity in patients with chronic urticaria? Allergy 2009: 64; 652-656. IF: 6.38 |
| 76 | Młynek, A., Magerl, M., Hanna, M., Lhachimi, S., Baiardini, I., Canonica, G. W., Brzoza, Z., Kasperska-Zajac, A., Rogala, B., Zalewska-Janowska, A., Zuberbier, T., and Maurer, M.+: The German version of the chronic urticaria quality-of-life questionnaire (CU-Q2oL): Factor analysis, validation and initial clinical findings. Allergy 2009: 64; 927-936. IF: 6.38 |
o.076
| 137. | Folkerts, J., Stadhouders, R., Redegeld, F. A., Tam, S. Y., Hendriks, R. W., Galli, S., and Maurer, M.+: Effect of dietary fiber and metabolites on mast cell activation and mast cell-associated diseases. Front. Immunol. 2018: 9; 1067. eCollection. IF: 4.72 |
| 186 | Altrichter, S., Salow, J., Ardelean, E., Church, M. K.+, Werner, A., and Maurer, M.: Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J. Dermatol. Sci. 2014: 75; 88-93. IF: 3.42 |
o.186
| 195 | Hawro, T., Fluhr, J. W., Mengeaud, V., Redoulès, D., Church, M. K., Maurer, M. and Metz, M.+: Polidocanol inhibits cowhage – but not histamine-induced itch in humans. Exp. Dermatol. 2014: 23; 922-941. IF: 3.76 |